Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia

Experimental Neurology

Volumn 209, Issue 1, 2008, Pages 192-198

  Piscopo, Paola ^a   Bernardo, Antonietta ^a   Calamandrei, Gemma ^a   Venerosi, Aldina ^a   Valanzano, Angela ^a   Bianchi, Daniela ^a   Confaloni, Annamaria ^a   Minghetti, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Brain; Cyclooxygenase; Hypoxia ischemia; Isoprostanes; Oxidative stress; Presenilin; Superoxide dismutase

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; ENZYME; MANGANESE SUPEROXIDE DISMUTASE; OXYGEN RADICAL; PRESENILIN; SCAVENGING ENZYME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BRAIN DAMAGE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLOBAL PERINATAL ASPHYXIA; HIPPOCAMPUS; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERINATAL ASPHYXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION;

ANIMALS; ASPHYXIA; BLOTTING, WESTERN; BODY WEIGHT; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; ISOPROSTANES; OXIDATIVE STRESS; PREGNANCY; PRESENILINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

EID: 37549007657     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.09.014     Document Type: Article

References (43)

1. 2-isoprostanes. Ann. Neurol. 58 (2005) 108-120
2. Bayir H., Kagan V.E., Tyurina Y.Y., Tyurin V., Ruppel R.A., Adelson P.D., Graham S.H., Janesko K., Clark R.S., and Kochanek P.M. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr. Res. 51 (2002) 571-578
3. Bernardo A., Gasparini L., Ongini E., and Minghetti L. Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: implications for chronic treatments of neurodegenerative diseases. Neurobiol. Dis. 22 (2006) 25-32
4. Bjelke B., Andersson K., Ogren S.O., and Bolme P. Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission. Brain Res. 543 (1991) 1-9
5. Calamandrei G., Venerosi A.P., Valanzano A., De Berardinis M.A., Greco A., Puopolo M., and Minghetti L. Increased brain levels of F2-isoprostane are an early marker of behavioral sequels in a rat model of global perinatal asphyxia. Pediatr. Res. 55 (2004) 85-92
6. Crestini A., Napolitano M., Piscopo P., Confaloni A., and Bravo E. Changes in cholesterol metabolism are associated with PS1 and PS2 gene regulation in SK-N-BE. J. Mol. Neurosci. 30 (2006) 311-322
7. de Haan M., Wyatt J.S., Roth S., Vargha-Khadem F., Gadian D., and Mishkin M. Brain and cognitive-behavioural development after asphyxia at term birth. Dev. Sci. 9 (2006) 350-358
8. Donoviel D.B., Hadjantonakis A., Ikeda M., Zheng H., Hyslop P., and Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13 (1999) 2801-2810
9. Fullerton H.J., Ditelberg J.S., Chen S.F., Sarco D.P., Chan P.H., Epstein C.J., and Ferriero D.M. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann. Neurol. 44 (1998) 357-364
10. Fuso A., Cavallaro R.A., Zampelli A., D'Anselmi F., Piscopo P., Confaloni A., and Scarpa S. γ-secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J. Alzheimer's Dis. 11 (2007) 275-290
11. Greco A., and Minghetti L. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases. Curr. Neurovasc. Res. 1 (2004) 341-354
12. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
13. Herreman A., Hartmann D., Annaert W., Saftig P., Craessaerts K., Serneels L., Umans L., Schrijvers V., Checler F., Vanderstichele H., Baekelandt V., Dressel R., Cupers P., Huylebroeck D., Zwijsen A., Van Leuven F., and De Strooper B. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin1 deficiency. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11872-11877
14. Hoeger H., Engidawork E., Stolzlechner D., Bubna-Littitz H., and Lubec B. Long-term effect of moderate and profound hypothermia on morphology, neurological, cognitive and behavioural functions in a rat model of perinatal asphyxia. Amino Acids 31 (2006) 385-396
15. Iadecola C., and Alexander M. Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14 (2001) 89-94
16. Iadecola C., Forster C., Nogawa S., Clark H.B., and Ross M.E. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol. (Berl.) 98 (1999) 9-14
17. Inder T., Mocatta T., Darlow B., Spencer C., Volpe J.J., and Winterbourn C. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr. Res. 52 (2002) 213-218
18. Inder T., Mocatta T., Darlow B., Spencer C., Senthilmohan R., Winterbourn C.C., and Volpe J.J. Markers of oxidative injury in the cerebrospinal fluid of a premature infant with meningitis and periventricular leukomalacia. J. Pediatr. 140 (2002) 617-621
19. Ishitani R., Tajima H., Takata H., Tsuchiya K., Kuwae T., Yamada M., Takahashi H., Tatton N.A., and Katsube N. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 (2003) 291-301
20. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2317-2321
21. Kaufmann W.E., Worley P.F., Taylor C.V., Bremer M., and Isakson P.C. Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome. Brain Develop. 19 (1997) 25-34
22. Khan J.Y., and Black S.M. Developmental changes in murine brain antioxidant enzymes. Pediatr. Res. 54 (2003) 77-82
23. Koistinaho J., Koponen S., and Chan P.H. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. Stroke 30 (1999) 1900-1905
24. Lawson J.A., Rokach J., and FitzGerald G.A. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem. 274 (1999) 24441-24444
25. Lu S., Gu X., Hoestje S., and Epner D.E. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim. Biophys. Acta 1574 (2002) 152-156
26. Mattson M.P., Zhu H., Yu J., and Kindy M.S. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 20 (2000) 1358-1364
27. McLean C., and Ferriero D. Mechanisms of hypoxic-ischemic injury in the term infant. Semin. Perinatol. 28 (2004) 425-432
28. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
29. Minghetti L., Greco A., Cardone F., Puopolo M., Ladogana A., Almonti S., Cunningham C., Perry V.H., Pocchiari M., and Levi G. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol. 59 (2000) 866-871
30. Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M.A., Greco A., Levi G., and Minghetti L. In vivo activation of N-methyl-d-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J. Neurochem. 81 (2002) 1028-1034
31. Planas A.M., Soriano M.A., Rodriguez-Farre E., and Ferrer I. Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain. Neurosci. Lett. 200 (1995) 187-190
32. Qin Y., Wang C.C., Kuhn H., Rathmann J., Pang C.P., and Rogers M.S. Determinants of umbilical cord arterial 8-iso-prostaglandin F2α concentrations. BJOG 107 (2000) 973-981
33. Ricceri L., Minghetti L., Moles A., Popoli P., Confaloni A., De Simone R., Piscopo P., Scattoni M.L., di Luca M., and Calamandrei G. Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp. Neurol. 189 (2004) 162-172
34. Sairanen T., Ristimaki A., Karjalainen-Lindsberg M.L., Paetau A., Kaste M., and Lindsberg P.J. Cyclooxygenase-2 is induced globally in infarcted human brain. Ann. Neurol. 43 (1998) 738-747
35. Scheepens A., Wassink G., Piersma M.J., Van de Berg W.D., and Blanco C.E. A delayed increase in hippocampal proliferation following global asphyxia in the neonatal rat. Brain Res. Dev. Brain Res. 42 (2003) 67-76
36. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., and Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89 (1997) 629-639
37. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar J.F., Foncin L., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A.R., Hanes J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., and St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
38. Toti P., De Felice C., Schurfeld K., Stumpo M., Bartolommei S., Lombardi A., Petraglia E., and Buonocore G. Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain. An autopsy study. J. Submicrosc. Cytol. Pathol. 33 (2001) 245-249
39. Van de Berg W.D., Schmitz C., Steinbusch H.W., and Blanco C.E. Perinatal asphyxia induced neuronal loss by apoptosis in the neonatal rat striatum: a combined TUNEL and stereological study. Exp. Neurol. 174 (2002) 29-36
40. Varma S., Janesko K.L., Wisniewski S.R., Bayir H., Adelson P.D., Thomas N.J., and Kochanek P.M. F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. J. Neurotrauma 20 (2003) 781-786
41. Venerosi A., Valanzano A., Cirulli F., Alleva E., and Calamandrei G. Acute global anoxia during C-section birth affects dopamine-mediated behavioural responses and reactivity to stress. Behav. Brain Res. 154 (2004) 155-164
42. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 50 (2001) 553-562
43. Wines-Samuelson M., and Shen J. Presenilins in the developing, adult, and aging cerebral cortex. Neuroscientist 11 (2005) 441-451